Dr. Adrian U Wiestner, M.D.
Claim this profileStudies Lymphoma
Studies T-Lymphoblastic Leukemia/Lymphoma
1 reported clinical trial
3 drugs studied
More about Adrian U Wiestner, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Adrian U Wiestner, M.D. has experience with
- Fludarabine
- Ibrutinib
- Pembrolizumab
Breakdown of trials Adrian U Wiestner, M.D. has run
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
B-Cell Leukemia
Chronic Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adrian U Wiestner, M.D. specialize in?
Adrian U Wiestner, M.D. focuses on Lymphoma and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Adrian U Wiestner, M.D. currently recruiting for clinical trials?
No, Adrian U Wiestner, M.D. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Adrian U Wiestner, M.D. has studied deeply?
Yes, Adrian U Wiestner, M.D. has studied treatments such as Fludarabine, Ibrutinib, Pembrolizumab.
What is the best way to schedule an appointment with Adrian U Wiestner, M.D.?
Apply for one of the trials that Adrian U Wiestner, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.